Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. DrugBank Drug (Description in trials) KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1 PEG-interleukin-2
(Polyethylene glycol-modified recombinant interleukin-2)		[1] PEG-interleukin-2---[1] 65 💬
2 Peginterferon beta-1a
(Polyethylene glycol-interferon beta-1a)		[1] Peginterferon BETA-1A[1] Peginterferon beta-1a 💬 [2] IFNAR1,
IFNAR2 💬 		[18] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬[1] 13 💬
3 Polidocanol
(Polyethylene glycol 450 lauryl ether)		[1] Polidocanol[2] Laureth 4 ,
Polidocanol 💬 		--[3] 34, 278, 279 💬
4 Polyethylene glycol
(Polyethylene glycol)		[3] Macrogol; Macrogol 3350; Polyethylene glycol[3] Polyethylene glycol 3350 (Polyethylene glycol 3350, Polyethylene glycol),
Macrogol 4000 ,
Macrogol 6000 💬 		--[15] 6, 13, 26, 41, 46, 50, 60, 65, 76, 96, 97, 195, 246, 299, 337 💬